The Leukemia and Lymphoma Society recently named Louis DeGennaro its president and CEO. DeGennaro had served as interim president and CEO of the White Plains-based cancer patient advocacy agency since February.
“Dr. DeGennaro has tirelessly dedicated himself for almost a decade of service to the (Leukemia and Lymphoma Society) mission and to the patients whom we all serve, and this appointment is in recognition of his vision, leadership and commitment to the LLS mission,” said James H. Davis, chairman of the society’s board of directors, in a statement.
DeGennaro has more than 25 years of research, drug development and executive management experience in academic and private sector settings. His appointment follows a national search and the consideration of internal and external candidates.
The Leukemia and Lymphoma Society funds research on blood cancer and provides free information and support services.
